- Home
- NCNA vs FRSX Comparison
NCNA vs FRSX Comparison
Compare NCNA & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCNA
- FRSX
- Stock Information
- Founded
- NCNA 1997
- FRSX N/A
- Country
- NCNA United Kingdom
- FRSX Israel
- Employees
- NCNA N/A
- FRSX N/A
- Industry
- NCNA Biotechnology: Pharmaceutical Preparations
- FRSX Computer Software: Prepackaged Software
- Sector
- NCNA Health Care
- FRSX Technology
- Exchange
- NCNA Nasdaq
- FRSX Nasdaq
- Market Cap
- NCNA 7.6M
- FRSX 7.1M
- IPO Year
- NCNA 2017
- FRSX 2017
- Fundamental
- Price
- NCNA $5.77
- FRSX $2.30
- Analyst Decision
- NCNA
- FRSX
- Analyst Count
- NCNA 0
- FRSX 0
- Target Price
- NCNA N/A
- FRSX N/A
- AVG Volume (30 Days)
- NCNA 676.6K
- FRSX 43.3K
- Earning Date
- NCNA 11-24-2025
- FRSX 11-28-2025
- Dividend Yield
- NCNA N/A
- FRSX N/A
- EPS Growth
- NCNA N/A
- FRSX N/A
- EPS
- NCNA N/A
- FRSX N/A
- Revenue
- NCNA N/A
- FRSX $452,000.00
- Revenue This Year
- NCNA N/A
- FRSX N/A
- Revenue Next Year
- NCNA N/A
- FRSX N/A
- P/E Ratio
- NCNA N/A
- FRSX N/A
- Revenue Growth
- NCNA N/A
- FRSX N/A
- 52 Week Low
- NCNA $2.78
- FRSX $1.98
- 52 Week High
- NCNA $426.00
- FRSX $18.41
- Technical
- Relative Strength Index (RSI)
- NCNA 60.59
- FRSX 63.87
- Support Level
- NCNA $5.20
- FRSX $2.06
- Resistance Level
- NCNA $7.01
- FRSX $2.48
- Average True Range (ATR)
- NCNA 0.72
- FRSX 0.12
- MACD
- NCNA 0.10
- FRSX -0.04
- Stochastic Oscillator
- NCNA 61.67
- FRSX 54.55
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
About FRSX Foresight Autonomous Holdings Ltd.
Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.